A selection of candidate compounds for in vitro teratogenesis test validation
Authors:
- 1 January 1983
- journal article
- research article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 3 (6) , 461-480
Abstract
The Consensus Workshop on In Vitro Teratogenesis Testing recommended that test validation be facilitated by a listing of agents with defined teratogenicity; subsequently, a panel was convened to review and select such agents. This communication establishes a list of 47 compounds or conditions which demonstrate a wide range of teratogenicity in vivo. The agents were chosen primarily on the strength of the literature base denoting their in vivo effects. The tables note a number of general biological and toxicological characteristics for each agent, and the details of representative in vivo teratology studies are summarized and referenced. This list is intended to serve as a base for in vitro teratogenesis test validation and should prove useful in developing and identifying those systems which will contribute to a more effective testing program.Keywords
This publication has 130 references indexed in Scilit:
- Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoidsJournal of the American Academy of Dermatology, 1982
- Carcinogenic and teratogenic activities of diethylstilbestrol in miceLife Sciences, 1980
- Teratogenic and cytogenetic effects of some plant‐derived antitumor agents (vincristine, colchicine, maytansine, VP‐16‐213 and VM‐26) in miceTeratology, 1978
- Teratogenicity of ethylenethiourea and thyroid function in the ratTeratology, 1978
- Drug‐induced limb dysplasias in fetal rabbitsTeratology, 1977
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- DNA synthesis inhibition and cell death associated with hydroxyurea teratogenesis in rat embryosDevelopmental Biology, 1971
- Methotrexate-induced congenital malformationsThe Journal of Pediatrics, 1968
- Teratogenic activity of thalidomide and related compoundsLife Sciences, 1964
- Pharmacological properties and teratogenic action of 2-[Hexahydrophthalimido] glutarimide and 2-phthalimido-N-methylglutarimideLife Sciences, 1964